To see this page, please, enable javaScript and styleSheets on your browser: Tools -> Internet Options ...
Reload !
Gene MSRB3TABLE OF CONTENTS / OPEN CLOSE ALL PARAGRAPHS
Summary back to top
Compact gene diagram back to top
244 supporting clones for gene MSRB3 back to top
cDNA accession
Links to the sequence
Tissue

most 5' clones
in red
Match
mRNA
From bp
to bp
in mRNA
From bp
to bp
in accs.
Clone encodes
complete protein
(with AA variation)
Features Anomalies
detected by
AceView
Accession
match over
(% length)
Base differences
relative to genome
(% identity)
DT219206 brain .a 1 to 649 2 to 650   tiling clone,   650/650
(100 %)
0 diff
(100 %id)
DC357690   .a 1 to 451 2 to 452       452/561
(80 %)
6 diff
(99.0 %id)
NM_198080.3   .a 1 to 4282 2 to 4283 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 4283/4283
(100 %)
0 diff
(100 %id)
AK316365 esophagus, tumor tissue .a 29 to 1278 1 to 1251       1251/1251
(100 %)
3 diff
(99.8 %id)
DC357844   .a 29 to 595 1 to 567       567/567
(100 %)
1 diff
(99.9 %id)
DC394111 esophageal, tumor tissue .a 29 to 536 1 to 508       508/508
(100 %)
1 diff
(99.9 %id)
BJ991348 hepatoblastoma .a 37 to 622 1 to 586       586/586
(100 %)
0 diff
(100 %id)
DC347408 tongue, tumor tissue .a 40 to 602 1 to 563       563/563
(100 %)
0 diff
(100 %id)
DC422244 uterus .a 57 to 607 1 to 551       551/551
(100 %)
0 diff
(100 %id)
AK299065   .a 61 to 1547 1 to 1488       1488/1488
(100 %)
3 diff
(99.8 %id)
DC369526   .a 61 to 609 1 to 549       549/549
(100 %)
0 diff
(100 %id)
AY358229   .a 65 to 1830 1 to 1766   tiling clone,   1766/1766
(100 %)
0 diff
(100 %id)
DN997579 breast cancer, Mammary gland (cancer tissue) .a 66 to 518 9 to 461       453/461
(98 %)
6 diff
(98.7 %id)
BI257829 cervical carcinoma cell line, cervix .a 91 to 892 1 to 803       803/803
(100 %)
10 diff
(98.8 %id)
BJ991349 hepatoblastoma .a 1272 to 1809 538 to 1       538/538
(100 %)
1 diff
(99.9 %id)
BX500552 Liver .b 1 to 632 1 to 632   tiling clone,   632/632
(100 %)
6 diff
(99.1 %id)
NM_001193461.1   .b 3 to 4274 1 to 4272 exact RefSeq, AAA   4272/4272
(100 %)
0 diff
(100 %id)
NM_001031679.2   .c 1 to 4409 2 to 4410 exact RefSeq, AAA   4410/4410
(100 %)
0 diff
(100 %id)
DA165107 amygdala .c 1 to 568 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
BJ991157 hepatoblastoma .c 1 to 578 1 to 578   tiling clone,   578/583
(99 %)
6 diff
(99.0 %id)
DA652313   .c 1 to 538 2 to 539   capped   538/538
(100 %)
0 diff
(100 %id)
DB248286 uterus .c 27 to 663 2 to 639   capped   638/640
(99 %)
2 diff
(99.7 %id)
AK293084 uterus .c 30 to 1123 1 to 1094 exact     1094/1094
(100 %)
1 diff
(100.0 %id)
DA879375 Prostate .c 30 to 597 2 to 569   capped   568/568
(100 %)
0 diff
(100 %id)
DB283694 uterus .c 31 to 576 2 to 547   capped   546/546
(100 %)
6 diff
(99.0 %id)
DA134499 alzheimer cortex .c 41 to 578 2 to 539   capped   538/554
(97 %)
8 diff
(98.6 %id)
DB257819 uterus .c 41 to 601 2 to 562   capped   561/561
(100 %)
0 diff
(100 %id)
DA536428 heart .c 58 to 660 2 to 604   capped   603/604
(99 %)
1 diff
(99.9 %id)
DB242498 stomach, tumor tissue .c 60 to 560 2 to 502   capped   501/501
(100 %)
0 diff
(100 %id)
DB248140 uterus .c 60 to 540 2 to 482   capped   481/481
(100 %)
0 diff
(100 %id)
DA821147 pericardium .c 62 to 633 2 to 571   capped   570/570
(100 %)
1 diff
(99.9 %id)
DB456498.
matches multiple genes
testis .c 64 to 541 1 to 478     also hits gene deynar 478/508
(94 %)
4 diff
(99.3 %id)
BX648776 uterus .c 81 to 4409 1 to 4330 exact tiling clone, available from DKFZ, AAA   4330/4330
(100 %)
4 diff
(100.0 %id)
AL833622 human endometrium carcinoma cell line .c 82 to 2759 1 to 2677 Q130R R149I tiling clone, available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 2677/2677
(100 %)
6 diff
(99.8 %id)
BM712298 eye, lens .c 82 to 331 1 to 250       250/251
(99 %)
6 diff
(97.7 %id)
DA326300 hippocampus .c 90 to 642 2 to 554   capped   553/553
(100 %)
0 diff
(100 %id)
DA326304 hippocampus .c 90 to 564 2 to 476   capped   475/475
(100 %)
0 diff
(100 %id)
DB261187 uterus .c 90 to 656 2 to 568   capped   567/567
(100 %)
0 diff
(100 %id)
BX500834 Liver .c 128 to 499 1 to 372       372/372
(100 %)
1 diff
(99.8 %id)
BM147323 leukopheresis .c 173 to 689 1 to 517       517/518
(99 %)
5 diff
(99.1 %id)
DR006225 Prostate .c 214 to 557 1 to 344       344/344
(100 %)
0 diff
(100 %id)
BM670963 eye, lens .c 487 to 897 429 to 19   AAA   411/411
(100 %)
1 diff
(99.8 %id)
BJ991158 hepatoblastoma .c 1395 to 1934 540 to 1       540/540
(100 %)
1 diff
(99.9 %id)
DB350954 uterus .c 1401 to 1950 556 to 7   tiling clone,   550/556
(98 %)
0 diff
(100 %id)
NM_001193460.1   .d 1 to 4573 2 to 4574 exact RefSeq, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 4574/4574
(100 %)
0 diff
(100 %id)
BC040053 Pancreas, epithelioid carcinoma .d 99 to 1061 1 to 963 exact tiling clone, available from MGC, AAA   963/963
(100 %)
0 diff
(100 %id)
BQ422650 epithelioid carcinoma, Pancreas .d 100 to 979 1 to 898       898/901
(99 %)
28 diff
(96.9 %id)
BU624540 cell lines, Enchondroma .d 383 to 1061 696 to 19 exact AAA   678/687
(98 %)
2 diff
(99.8 %id)
BU785369 Pancreas, Purified pancreatic islet .d 386 to 896 147 to 657       511/657
(77 %)
6 diff
(99.1 %id)
CK902687 Pancreas, Purified pancreatic islet .d 386 to 878 78 to 570     Submitted on the opposite strand 493/570
(86 %)
6 diff
(99.0 %id)
BQ017894 lung, Metastatic Chondrosarcoma .d 419 to 1066 666 to 19 S2F AAA   648/648
(100 %)
1 diff
(99.9 %id)
AB076971 breast, vestibule .d 426 to 560 135 to 1       135/135
(100 %)
0 diff
(100 %id)
EL734474 mixed .d 438 to 994 1 to 557       557/649
(85 %)
0 diff
(100 %id)
TI_1948211303   .d 438 to 895 140 to 597       458/486
(94 %)
6 diff
(98.8 %id)
TI_1948211584   .d 438 to 982 133 to 678       546/576
(94 %)
11 diff
(98.1 %id)
TI_1948211858   .d 438 to 988 139 to 689       551/580
(95 %)
6 diff
(99.0 %id)
BU785092 Pancreas, Purified pancreatic islet .d 468 to 1042 575 to 1       575/575
(100 %)
0 diff
(100 %id)
AI186683 lung .d 544 to 1060 520 to 2       519/520
(99 %)
2 diff
(99.7 %id)
AI147793 senescent fibroblast .d 552 to 1068 516 to 3       514/516
(99 %)
4 diff
(99.3 %id)
AI911089 pooled .d 552 to 1062 513 to 3       511/513
(99 %)
4 diff
(99.3 %id)
BQ372028 prostate_normal .d 576 to 996 437 to 21       417/437
(95 %)
4 diff
(99.1 %id)
AI066548 pooled .d 585 to 1068 487 to 4       484/487
(99 %)
1 diff
(99.8 %id)
AI189186 uterus .d 595 to 945 351 to 1       351/352
(99 %)
1 diff
(99.8 %id)
AI288929 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 612 to 1068 459 to 3       457/459
(99 %)
0 diff
(100 %id)
BQ371983 prostate_normal .d 621 to 1007 19 to 405       387/406
(95 %)
13 diff
(96.8 %id)
AW068594 Bone, Hip .d 634 to 1215 8 to 591       584/591
(98 %)
8 diff
(98.7 %id)
AW451989   .d 643 to 1061 436 to 18   AAA   419/429
(97 %)
0 diff
(100 %id)
BM711517 eye, optic nerve .d 701 to 1066 12 to 377   AAA   366/377
(97 %)
0 diff
(100 %id)
DR762471 embryonic stem .d 803 to 1568 13 to 777   tiling clone,   765/777
(98 %)
6 diff
(99.3 %id)
BX640871 human endometrium carcinoma cell line .d 832 to 2923 1 to 2092   available from DKFZ, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 2092/2092
(100 %)
6 diff
(99.8 %id)
AL599751   .d 841 to 1423 5 to 588       584/588
(99 %)
4 diff
(99.4 %id)
DA443059 tongue, tumor tissue .d 1099 to 1674 2 to 578   capped   577/577
(100 %)
2 diff
(99.7 %id)
BX484352   .d 1099 to 1590 1 to 493       493/493
(100 %)
6 diff
(98.8 %id)
DA580141   .d 1163 to 1717 2 to 556   capped   555/555
(100 %)
0 diff
(100 %id)
DA720605   .d 1182 to 1734 2 to 554   capped   553/553
(100 %)
1 diff
(99.9 %id)
TI_154092315   .d 1204 to 2149 987 to 58       930/987
(94 %)
0 diff
(100 %id)
BM688817 eye, optic nerve .d 1410 to 1873 1 to 465       465/465
(100 %)
8 diff
(98.3 %id)
CA434549 lung, Metastatic Chondrosarcoma .d 1423 to 2119 716 to 19   AAA Possibly primed on the genome, locally A rich (15/17 A in genome downstream of last aligned base) 698/698
(100 %)
3 diff
(99.6 %id)
BG752666 eye, normal pigmented retinal epithelium .d 1431 to 2168 1 to 739       739/739
(100 %)
4 diff
(99.5 %id)
BG752976 eye, normal pigmented retinal epithelium .d 1431 to 2117 1 to 688   tiling clone,   688/688
(100 %)
2 diff
(99.8 %id)
AW080939 colon, moderately differentiated adenocarcinoma .d 1491 to 2123 636 to 1       636/647
(98 %)
17 diff
(97.4 %id)
CA439934 lung, Lung Focal Fibrosis .d 1502 to 2120 1 to 618   AAA Submitted on the opposite strand 618/619
(99 %)
5 diff
(99.2 %id)
DA725241   .d 1515 to 2092 2 to 579   capped   578/578
(100 %)
1 diff
(99.9 %id)
AA442533   .d 1517 to 1762 1 to 246       246/251
(98 %)
1 diff
(99.7 %id)
AI204304 lung .d 1619 to 2118 500 to 1       500/500
(100 %)
1 diff
(99.8 %id)
AL602613 human skeletal muscle .d 1620 to 2214 1 to 595       595/595
(100 %)
0 diff
(100 %id)
N94311 senescent fibroblast .d 1659 to 2125 467 to 1       467/468
(99 %)
4 diff
(99.2 %id)
BX471639   .d 1673 to 2301 7 to 640       634/640
(99 %)
6 diff
(99.1 %id)
BX501679 Liver .d 1763 to 2346 1 to 585       585/585
(100 %)
4 diff
(99.4 %id)
AW861510 colon .d 1822 to 2237 261 to 674       414/674
(61 %)
6 diff
(99.2 %id)
AL703136 human skeletal muscle .d 1879 to 2463 1 to 585       585/585
(100 %)
6 diff
(99.0 %id)
CN277631 embryonic stem cell, retinoic acid andmitogen-treated hES cell line H7 .d 1886 to 2666 5 to 786   tiling clone,   782/786
(99 %)
7 diff
(99.2 %id)
AK094185   .d 1944 to 4579 1 to 2636   tiling clone, available from FLJ,   2636/2636
(100 %)
2 diff
(100.0 %id)
DA031789   .d 1945 to 2517 2 to 574   capped   573/573
(100 %)
0 diff
(100 %id)
DA028691   .d 1955 to 2519 2 to 566   capped   565/565
(100 %)
0 diff
(100 %id)
DA387841 thalamus .d 1965 to 2536 2 to 573   capped   572/572
(100 %)
0 diff
(100 %id)
AW771118 colon, juvenile granulosa tumor .d 1967 to 2295 328 to 1       328/328
(100 %)
2 diff
(99.4 %id)
CA392724 eye, RPE/choroid .d 1969 to 2512 1 to 544       544/544
(100 %)
0 diff
(100 %id)
BU521681 leiomyosarcoma, uterus .d 1994 to 2856 1 to 874       874/915
(95 %)
6 diff
(99.4 %id)
BE904410 epithelioid carcinoma, Pancreas .d 2024 to 2613 1 to 608       608/862
(70 %)
28 diff
(96.8 %id)
AA149451 uterus .d 2041 to 2424 1 to 388   fully sequenced,   388/388
(100 %)
11 diff
(97.2 %id)
N88273   .d 2082 to 2429 1 to 346       346/348
(99 %)
26 diff
(92.6 %id)
BI259162 cervical carcinoma cell line, cervix .d 2091 to 2895 1 to 808       808/808
(100 %)
6 diff
(99.3 %id)
AL049150 testis .d 2117 to 2610 1 to 494       494/494
(100 %)
0 diff
(100 %id)
ES308215 beard hair, skin .d 2144 to 2308 1 to 162       162/162
(100 %)
3 diff
(98.2 %id)
AA179402   .d 2156 to 2633 1 to 478   fully sequenced,   478/478
(100 %)
0 diff
(100 %id)
T90437 lung .d 2165 to 2526 1 to 369       369/373
(98 %)
13 diff
(96.6 %id)
AA449853   .d 2207 to 2640 1 to 434       434/434
(100 %)
1 diff
(99.8 %id)
AA376102 lung .d 2238 to 2526 1 to 292       292/307
(95 %)
4 diff
(98.7 %id)
AA195216 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2290 to 2705 4 to 416   fully sequenced, Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 413/416
(99 %)
14 diff
(96.7 %id)
AA232623 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2290 to 2614 4 to 328   fully sequenced, Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 325/328
(99 %)
5 diff
(98.5 %id)
DA709349   .d 2294 to 2867 2 to 575   capped   574/574
(100 %)
0 diff
(100 %id)
AA036798 uterus .d 2296 to 2752 10 to 472       463/476
(97 %)
8 diff
(98.4 %id)
AV761147 bone marrow .d 2304 to 3024 1 to 720       720/730
(98 %)
15 diff
(98.0 %id)
AL048386 uterus .d 2314 to 3123 821 to 11       811/824
(98 %)
0 diff
(100 %id)
BE074244 breast .d 2360 to 2881 1 to 521       521/521
(100 %)
2 diff
(99.7 %id)
DA716855   .d 2384 to 2927 2 to 545   capped   544/544
(100 %)
0 diff
(100 %id)
AA151588 uterus .d 2414 to 2923 512 to 1   fully sequenced,   512/512
(100 %)
14 diff
(97.3 %id)
AA122080 uterus .d 2448 to 2879 1 to 431   fully sequenced,   431/431
(100 %)
0 diff
(100 %id)
CF552834 Pooled muscle (cardiac and skeletal) .d 2448 to 3300 1 to 855   tiling clone,   855/886
(96 %)
3 diff
(99.7 %id)
W30707 senescent fibroblast .d 2522 to 3004 10 to 496       487/496
(98 %)
6 diff
(98.8 %id)
AI373125 uterus .d 2546 to 2915 399 to 30   AAA   370/378
(97 %)
0 diff
(100 %id)
DA063888 cerebellum .d 2548 to 3114 2 to 569   capped   568/568
(100 %)
1 diff
(99.9 %id)
AA029085 uterus .d 2550 to 2714 1 to 167   fully sequenced,   167/167
(100 %)
5 diff
(97.1 %id)
BE843641 testis_normal .d 2573 to 2825 254 to 2       253/254
(99 %)
0 diff
(100 %id)
BE843646 testis_normal .d 2573 to 2825 254 to 2       253/254
(99 %)
0 diff
(100 %id)
AI224508 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2583 to 3035 453 to 1       453/453
(100 %)
4 diff
(99.2 %id)
AI379659 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2583 to 3035 453 to 1       453/453
(100 %)
1 diff
(99.8 %id)
AA232570 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2584 to 2923 356 to 17   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 340/340
(100 %)
0 diff
(100 %id)
AA179403   .d 2603 to 3108 503 to 1   fully sequenced,   503/503
(100 %)
5 diff
(99.1 %id)
AA195322 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .d 2675 to 2923 271 to 22   fully sequenced, AAA Possibly primed on the genome, locally A rich (12/14 A in genome downstream of last aligned base) 250/250
(100 %)
0 diff
(100 %id)
AA029086 uterus .d 2707 to 3101 408 to 1   fully sequenced,   408/408
(100 %)
17 diff
(95.9 %id)
AA122081 uterus .d 2849 to 3035 185 to 1   fully sequenced,   185/185
(100 %)
1 diff
(99.5 %id)
DB295806   .d 4049 to 4579 531 to 1       531/531
(100 %)
0 diff
(100 %id)
DB313816 tongue, tumor tissue .d 4060 to 4579 520 to 1       520/542
(95 %)
1 diff
(99.9 %id)
N98419 senescent fibroblast .d 4137 to 4578 447 to 5       443/447
(99 %)
0 diff
(100 %id)
AA449815   .d 4181 to 4578 398 to 1       398/398
(100 %)
1 diff
(99.8 %id)
BM914782 amelanotic melanoma, cell line, skin .e 1 to 526 1 to 526 exact tiling clone, AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 526/526
(100 %)
0 diff
(100 %id)
AI271635 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .e 172 to 677 508 to 1   tiling clone,   508/508
(100 %)
3 diff
(99.5 %id)
BQ941753 sciatic nerve .f 1 to 869 2 to 873 exact tiling clone,   873/894
(97 %)
10 diff
(98.9 %id)
AJ239423 retinal pigment epithelium .g 1 to 419 1 to 423 T60H D61R D62* tiling clone,   423/423
(100 %)
17 diff
(96.0 %id)
BF377315 testis_normal .h-u 1 to 456 1 to 455 Y3L T8K G9A N10T R11E ... tiling clone,   455/455
(100 %)
3 diff
(99.4 %id)
DA130700 alzheimer cortex .i 1 to 526 2 to 527 exact tiling clone, capped   526/526
(100 %)
0 diff
(100 %id)
BG023974 duodenal adenocarcinoma, cell line, small intestine .j 1 to 738 1 to 735 exact tiling clone,   735/1085
(67 %)
19 diff
(98.3 %id)
DB234666 trachea .k-u 1 to 559 2 to 561   tiling clone, capped   560/560
(100 %)
1 diff
(99.9 %id)
AK122602   .k-u 1519 to 3464 1 to 1946 exact tiling clone, available from FLJ,   1946/1946
(100 %)
2 diff
(99.9 %id)
DA704289   .k-u 1520 to 2072 2 to 554   to resequence, capped   553/553
(100 %)
3 diff
(99.5 %id)
DA130678 alzheimer cortex .k-u 1525 to 2083 2 to 561   capped   560/560
(100 %)
1 diff
(99.9 %id)
BJ990503 hepatoblastoma .k-u 1540 to 2139 1 to 600       600/600
(100 %)
5 diff
(99.2 %id)
BQ380454 uterus_tumor .k-u 1552 to 1798 245 to 1       245/245
(100 %)
3 diff
(98.8 %id)
BQ380455 uterus_tumor .k-u 1552 to 1786 238 to 4       235/238
(98 %)
0 diff
(100 %id)
T60112 lung .k-u 1555 to 1784 1 to 232   fully sequenced,   232/232
(100 %)
0 diff
(100 %id)
AI685218 adenocarcinoma, Pancreas .k-u 1557 to 1977 1 to 422     Submitted on the opposite strand 422/422
(100 %)
7 diff
(98.4 %id)
AA663730 schizophrenic brain S-11 frontal lobe .k-u 1576 to 1935 1 to 360     Submitted on the opposite strand 360/360
(100 %)
2 diff
(99.5 %id)
AW451411   .k-u 1582 to 1997 430 to 16   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 415/415
(100 %)
3 diff
(99.3 %id)
BG546208 lung .k-u 1606 to 2367 1 to 764 F40S Y41I L42*     764/765
(99 %)
16 diff
(98.0 %id)
BQ233536 leiomyosarcoma, uterus .k-u 1619 to 2641 1 to 1029 G59X tiling clone,   1029/1029
(100 %)
31 diff
(97.0 %id)
AW451576   .k-u 1674 to 1997 341 to 18   AAA Possibly primed on the genome, locally A rich (8/8 A in genome downstream of last aligned base) 324/333
(97 %)
0 diff
(100 %id)
AA090694   .k-u 1694 to 2010 1 to 310       310/350
(88 %)
11 diff
(96.9 %id)
AA095105   .k-u 1694 to 1886 1 to 193       193/193
(100 %)
10 diff
(94.9 %id)
ES314574 occipital scalp hair, skin .k-u 1704 to 1861 1 to 158       158/158
(100 %)
0 diff
(100 %id)
AI685013 Kidney .k-u 1708 to 1997 290 to 1       290/290
(100 %)
1 diff
(99.7 %id)
BE645860 Prostate .k-u 1708 to 1997 290 to 1       290/290
(100 %)
0 diff
(100 %id)
DB350215 trachea .k-u 1718 to 1995 279 to 1       279/279
(100 %)
1 diff
(99.7 %id)
AU186049 skin .k-u 1722 to 1994 273 to 1       273/273
(100 %)
1 diff
(99.7 %id)
T60077 lung .k-u 1754 to 1997 248 to 1   fully sequenced,   248/248
(100 %)
3 diff
(98.8 %id)
CB111777 Liver .k-u 1758 to 2207 1 to 450       450/450
(100 %)
0 diff
(100 %id)
BY798760 eye .k-u 1772 to 2376 1 to 605 exact     605/605
(100 %)
0 diff
(100 %id)
BI027981 marrow .k-u 1774 to 1981 11 to 218       208/218
(95 %)
6 diff
(97.3 %id)
BE548818 cervical carcinoma cell line, cervix .k-u 1783 to 2562 1 to 754 exact     754/858
(87 %)
40 diff
(95.4 %id)
DQ786269   .k-u 1800 to 3471 1 to 1673 L9P R10K S11K L12P T13D ...     1673/1681
(99 %)
6 diff
(99.7 %id)
W31245 lung .k-u 1800 to 2229 1 to 438       438/438
(100 %)
11 diff
(97.5 %id)
H79889 liver and spleen .k-u 1850 to 2275 1 to 438       438/439
(99 %)
20 diff
(95.5 %id)
BG171064 hypernephroma, cell line, Kidney .k-u 1946 to 2651 1 to 702 exact     702/1031
(68 %)
10 diff
(99.1 %id)
BX089999 liver and spleen .k-u 2034 to 2773 1 to 742 exact     742/744
(99 %)
6 diff
(99.2 %id)
H77317 liver and spleen .k-u 2034 to 2382 1 to 355 exact     355/365
(97 %)
8 diff
(97.9 %id)
BM696298 eye, lens .k-u 2054 to 2679 1 to 626 exact     626/626
(100 %)
0 diff
(100 %id)
AA088603 uterus .k-u 2091 to 2486 1 to 396 T68X     396/396
(100 %)
3 diff
(99.3 %id)
AA336504 endometrium .k-u 2113 to 2368 1 to 256       256/256
(100 %)
0 diff
(100 %id)
CN430765 embryonic stem cells, embryoid bodiesderived from H1, H7 and H9 cells .k-u 2131 to 2810 1 to 680       680/680
(100 %)
3 diff
(99.6 %id)
BE810920 amnion_normal .k-u 2141 to 2489 1 to 347       347/357
(97 %)
4 diff
(98.9 %id)
EB387294 eye, optic nerve .k-u 2235 to 3112 1 to 878       878/878
(100 %)
0 diff
(100 %id)
AA249480   .k-u 2255 to 2558 1 to 302       302/302
(100 %)
5 diff
(98.4 %id)
CR600087 Placenta Cot 25-normalized .k-u 2284 to 3469 1 to 1186   tiling clone,   1186/1186
(100 %)
0 diff
(100 %id)
BF032112 hypernephroma, Kidney .k-u 2290 to 2884 1 to 588       588/837
(70 %)
17 diff
(98.0 %id)
BX358052 Placenta Cot 25-normalized .k-u 2297 to 3088 18 to 809       792/809
(97 %)
6 diff
(99.3 %id)
C04227 heart .k-u 2345 to 2728 1 to 384       384/384
(100 %)
0 diff
(100 %id)
C04681 heart .k-u 2357 to 2583 1 to 229       229/229
(100 %)
7 diff
(97.0 %id)
BM706446 eye, lens .k-u 2370 to 3017 1 to 648       648/648
(100 %)
0 diff
(100 %id)
BG548633 lung .k-u 2385 to 3172 1 to 798       798/799
(99 %)
22 diff
(97.3 %id)
CN430764 embryonic stem cells, cell lines H1, H7, andH9 .k-u 2392 to 3025 1 to 634       634/634
(100 %)
1 diff
(99.9 %id)
TI_159706069   .k-u 2436 to 3464 1119 to 97   AAA   1023/1044
(97 %)
20 diff
(98.1 %id)
BX358051 Placenta Cot 25-normalized .k-u 2585 to 3431 847 to 1       847/847
(100 %)
5 diff
(99.5 %id)
CD679455 eye, Trabecular meshwork .k-u 2596 to 3211 1 to 615       615/615
(100 %)
2 diff
(99.7 %id)
AA446539   .k-u 2596 to 3151 1 to 556   fully sequenced,   556/556
(100 %)
2 diff
(99.7 %id)
AA343562 gall bladder .k-u 2601 to 2945 1 to 343       343/343
(100 %)
4 diff
(98.9 %id)
AW952937   .k-u 2602 to 3120 1 to 520       520/522
(99 %)
5 diff
(99.1 %id)
TI_154115588   .k-u 2724 to 3470 835 to 92   AAA   744/939
(79 %)
25 diff
(97.4 %id)
CA426296 Bone, Subchondral Bone .k-u 2764 to 3470 725 to 19   AAA   707/707
(100 %)
0 diff
(100 %id)
BU630249 cell lines, Chondrosarcoma .k-u 2767 to 3470 714 to 13   AAA   702/702
(100 %)
2 diff
(99.8 %id)
BQ009327 Chondrosarcoma, Left Pubic Bone .k-u 2776 to 3470 707 to 13   AAA   695/695
(100 %)
0 diff
(100 %id)
W25518 senescent fibroblast .k-u 2779 to 3189 1 to 419   fully sequenced,   419/419
(100 %)
15 diff
(96.5 %id)
BF675050 Prostate .k-u 2781 to 3417 1 to 630       630/767
(82 %)
22 diff
(97.2 %id)
BG939817 bone marrow stroma .k-u 2794 to 3464 689 to 19   AAA   671/671
(100 %)
0 diff
(100 %id)
BG939656 bone marrow stroma .k-u 2824 to 3464 658 to 18   AAA   641/641
(100 %)
0 diff
(100 %id)
BM661792 eye, Retina Foveal and Macular .k-u 2872 to 3470 617 to 19   AAA   599/599
(100 %)
1 diff
(99.9 %id)
AW027333 thymus, pooled .k-u 2894 to 3470 577 to 1       577/577
(100 %)
0 diff
(100 %id)
BJ990504 hepatoblastoma .k-u 2911 to 3390 480 to 1       480/480
(100 %)
0 diff
(100 %id)
AI123421 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k-u 2934 to 3466 533 to 1       533/533
(100 %)
1 diff
(99.9 %id)
AW027211 thymus, pooled .k-u 2941 to 3470 530 to 1       530/530
(100 %)
0 diff
(100 %id)
DB323894   .k-u 2943 to 3464 523 to 1   to resequence,   523/523
(100 %)
1 diff
(99.9 %id)
C16396   .k-u 2959 to 3326 5 to 371       367/376
(97 %)
5 diff
(98.7 %id)
AW117569 pooled .k-u 2964 to 3471 514 to 7       508/514
(98 %)
0 diff
(100 %id)
N47745 multiple sclerosis lesions .k-u 2969 to 3220 1 to 254   fully sequenced,   254/254
(100 %)
0 diff
(100 %id)
D62342   .k-u 2976 to 3203 1 to 228       228/228
(100 %)
0 diff
(100 %id)
BX389607 Placenta Cot 25-normalized .k-u 2981 to 3469 1 to 487       487/487
(100 %)
3 diff
(99.4 %id)
AI095892 uterus .k-u 2988 to 3470 494 to 12   AAA   483/483
(100 %)
0 diff
(100 %id)
AA687603 normal prostate, Prostate .k-u 2999 to 3471 480 to 8       473/480
(98 %)
0 diff
(100 %id)
D62863   .k-u 3017 to 3454 1 to 432       432/432
(100 %)
8 diff
(98.2 %id)
D63070   .k-u 3017 to 3333 1 to 316       316/316
(100 %)
5 diff
(98.5 %id)
CA430107 cell lines, Chondrosarcoma .k-u 3017 to 3470 472 to 19   AAA   454/454
(100 %)
2 diff
(99.6 %id)
D61783   .k-u 3028 to 3359 1 to 332       332/332
(100 %)
0 diff
(100 %id)
AA688008 normal prostate, Prostate .k-u 3030 to 3470 441 to 1       441/441
(100 %)
0 diff
(100 %id)
AI367033 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k-u 3031 to 3471 444 to 4       441/444
(99 %)
0 diff
(100 %id)
AI127981 uterus .k-u 3038 to 3471 434 to 1       434/434
(100 %)
0 diff
(100 %id)
BF939170 Prostate .k-u 3044 to 3471 432 to 2       431/432
(99 %)
0 diff
(100 %id)
AW513375 colon, juvenile granulosa tumor .k-u 3050 to 3464 415 to 1       415/415
(100 %)
0 diff
(100 %id)
AW770826 colon, juvenile granulosa tumor .k-u 3051 to 3464 414 to 1       414/414
(100 %)
0 diff
(100 %id)
AW152674 poorly differentiated adenocarcinoma withsignet ring cell features, stomach .k-u 3059 to 3469 412 to 2       411/412
(99 %)
0 diff
(100 %id)
BF939165 Prostate .k-u 3060 to 3470 411 to 1       411/411
(100 %)
0 diff
(100 %id)
BQ219289 leiomyosarcoma, uterus .k-u 3070 to 3470 12 to 412   AAA   401/412
(97 %)
6 diff
(98.6 %id)
BF939162 Prostate .k-u 3074 to 3470 397 to 1       397/397
(100 %)
0 diff
(100 %id)
D62310   .k-u 3076 to 3331 1 to 256       256/256
(100 %)
0 diff
(100 %id)
D62090   .k-u 3089 to 3456 1 to 365       365/365
(100 %)
3 diff
(99.2 %id)
D62253   .k-u 3089 to 3351 1 to 261       261/261
(100 %)
6 diff
(97.8 %id)
BU735356 eye, lens .k-u 3090 to 3470 399 to 19   AAA   381/381
(100 %)
2 diff
(99.5 %id)
C16383   .k-u 3109 to 3411 1 to 303       303/309
(98 %)
1 diff
(99.7 %id)
AA446357   .k-u 3121 to 3474 354 to 1   fully sequenced,   354/354
(100 %)
3 diff
(99.2 %id)
AI085125 senescent fibroblast .k-u 3123 to 3470 348 to 1       348/348
(100 %)
0 diff
(100 %id)
N91811 lung .k-u 3132 to 3471 351 to 9       343/351
(97 %)
0 diff
(100 %id)
BM664304 eye, lens .k-u 3132 to 3470 357 to 19   AAA   339/339
(100 %)
2 diff
(99.5 %id)
H77318 liver and spleen .k-u 3143 to 3470 342 to 6       337/344
(97 %)
0 diff
(100 %id)
W19311 senescent fibroblast .k-u 3159 to 3475 320 to 1   fully sequenced,   320/320
(100 %)
7 diff
(97.9 %id)
D63027   .k-u 3161 to 3464 304 to 1       304/304
(100 %)
1 diff
(99.7 %id)
BM459533 leiomyosarcoma, uterus .k-u 3163 to 3464 34 to 335   AAA   302/335
(90 %)
6 diff
(98.3 %id)
D62827   .k-u 3165 to 3464 1 to 300       300/300
(100 %)
0 diff
(100 %id)
N34511 multiple sclerosis lesions .k-u 3190 to 3464 283 to 1   fully sequenced,   283/283
(100 %)
0 diff
(100 %id)
AW874507 tumor, uterus .k-u 3198 to 3470 295 to 23   AAA   273/275
(99 %)
6 diff
(97.9 %id)
D62620   .k-u 3208 to 3441 1 to 234       234/234
(100 %)
0 diff
(100 %id)
H79796 liver and spleen .k-u 3212 to 3464 253 to 1       253/253
(100 %)
2 diff
(99.3 %id)
AA343561 gall bladder .k-u 3223 to 3464 242 to 1       242/242
(100 %)
0 diff
(100 %id)
AI381727 mixed (see below), Pooled human melanocyte, fetal heart, andpregnant uterus .k-u 3249 to 3468 220 to 1       220/220
(100 %)
0 diff
(100 %id)
AW467732 myeloid cells, 18 pooled CML cases, BCR/ABLrearrangement positive, includes both chronic phase andmyeloid blast crisis, whole blood .k-u 3256 to 3464 208 to 1       208/208
(100 %)
1 diff
(99.6 %id)
AA548790 normal prostatic epithelial cells, Prostate .k-u 3290 to 3471 1 to 182       182/196
(92 %)
3 diff
(98.5 %id)
BG187173   .k-u 3381 to 3578 24 to 221       198/221
(89 %)
6 diff
(97.3 %id)
BG186680   .k-u 3421 to 3698 11 to 288   tiling clone,   278/288
(96 %)
6 diff
(98.0 %id)
BG188225   .k-u 3424 to 3698 55 to 326       272/326
(83 %)
6 diff
(98.2 %id)
BG201094   .k-u 3424 to 3698 15 to 289       275/289
(95 %)
6 diff
(98.0 %id)
BG219931   .k-u 3424 to 3698 14 to 288       275/288
(95 %)
6 diff
(98.0 %id)
BG200586   .k-u 3426 to 3698 15 to 287       273/287
(95 %)
6 diff
(98.0 %id)
AW292918   .l-u 1 to 576 1 to 575   tiling clone, Submitted on the opposite strand 575/575
(100 %)
6 diff
(99.0 %id)
DB286401 uterus .l-u 114 to 667 2 to 555   tiling clone, capped   554/554
(100 %)
1 diff
(99.9 %id)
AL600600   .l-u 560 to 1126 1 to 564   tiling clone,   564/564
(100 %)
5 diff
(99.2 %id)
AK126406 uterus .l-u 1085 to 3415 1 to 2331 exact tiling clone, available from FLJ,   2331/2331
(100 %)
4 diff
(99.9 %id)
DB262300 uterus .l-u 1086 to 1663 2 to 580 L32X V33G P34S V35C G36W ... capped   579/579
(100 %)
1 diff
(99.9 %id)
BE060971 breast .l-u 1341 to 1651 315 to 2     Submitted on the opposite strand 314/315
(99 %)
0 diff
(100 %id)
DB351699 uterus .l-u 2879 to 3415 537 to 1       537/537
(100 %)
1 diff
(99.9 %id)
BX503947   .m-u 1 to 611 1 to 611 exact tiling clone,   611/611
(100 %)
0 diff
(100 %id)
DA750430   .n 1 to 573 2 to 574 exact tiling clone, capped   573/573
(100 %)
0 diff
(100 %id)
DB452068.
matches multiple genes
testis .o 1 to 488 2 to 489 exact tiling clone, also hits gene deynar 489/489
(100 %)
1 diff
(99.8 %id)
BQ371881 prostate_normal Gene MSRB3, variant not shown         This clone was ignored    
? Gene Summary Gene on genome mRNA:.a, .b, .c, .d, .e, .f, .g, .h-u, .i, .j, .k-u, .l-u, .m-u, .n, .o Alternative mRNAs features, proteins, introns, exons, sequences Expression Tissue Function, regulation, related genes DC